SMMT•benzinga•
JMP Securities Initiates Coverage On Summit Therapeutics with Market Outperform Rating, Announces Price Target of $32
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga